Imagen de Portada

Código QR

Study of Ca2+-implication and immunogenicity of the regulated cell death induced by IMMUNEPOTENT CRP on breast cancer

Mostrar otras versiones (1)

Detalles Bibliográficos
Autor principal:	Reyes Ruiz, Alejandra
Formato:	Tesis
Lenguaje:	inglés
Publicado:	2020
Materias:	QR Microbiología
Acceso en línea:	http://eprints.uanl.mx/22304/1/1080315350.pdf

Ejemplares similares

Study of Ca2+-implication and immunogenicity of the regulated cell death induced by IMMUNEPOTENT CRP on breast cancer
por: Reyes Ruiz, Alejandra
Publicado: (2020)

Study of the mechanism and immunogenicity of the cell death induced by PKHB1 and Immunepotent-CRP in breast cancer
por: Calvillo Rodríguez, Kenny Misael
Publicado: (2023)

Study of the mechanism and immunogenicity of the cell death induced by PKHB1 and Immunepotent-CRP in breast cancer
por: Calvillo Rodríguez, Kenny Misael
Publicado: (2023)

Study of the immunogenicity of the cell death induced by the activation of CD47 in tumor cells
por: Calvillo Rodríguez, Kenny Misael
Publicado: (2019)

Study of the immunogenicity of the cell death induced by the activation of CD47 in tumor cells
por: Calvillo Rodríguez, Kenny Misael
Publicado: (2019)

IMMUNEPOTENT CRP induces cell cycle arrest and caspase-independent regulated cell death in HeLa cells through reactive oxygen species production
por: Martínez Torres, Ana Carolina, et al.
Publicado: (2018)

The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth
por: Rodríguez Salazar, María del Carmen, et al.
Publicado: (2017)

Synergistic Enhancement of Chemotherapy-Induced Cell Death and Antitumor Efficacy against Tumoral T-Cell Lymphoblasts by IMMUNEPOTENT CRP
por: Rivera Lazarín, Ana Luisa, et al.
Publicado: (2024)

Study of the effect of IMMUNEPOTENT CRP in combination with chemotherapies on cancer cells and immune system cells
por: Rivera Lazarín, Ana Luisa
Publicado: (2024)

Study of the effect of IMMUNEPOTENT CRP in combination with chemotherapies on cancer cells and immune system cells
por: Rivera Lazarín, Ana Luisa
Publicado: (2024)

Study of the effect of IMMUNEPOTENT-CRP on NK and T lymphocytes and T-acute lymphoblastic leukemia cell lines
por: Lorenzo Anota, Helen Yarimet
Publicado: (2022)

Study of the effect of IMMUNEPOTENT-CRP on NK and T lymphocytes and T-acute lymphoblastic leukemia cell lines
por: Lorenzo Anota, Helen Yarimet
Publicado: (2022)

Cytotoxic activity of IMMUNEPOTENT CRP against non-small cell lung cancer cell lines
por: Martínez Torres, Ana Carolina, et al.
Publicado: (2019)

Study of the antimetastatic effect of PKHB1 in breast, colon, and pancreatic cancer cells
por: Mendoza Reveles, Rodolfo
Publicado: (2024)

Study of the antimetastatic effect of PKHB1 in breast, colon, and pancreatic cancer cells
por: Mendoza Reveles, Rodolfo
Publicado: (2024)

El Immunepotent-CRP induce apoptosis en células leucémicas Molt-4
por: Lorenzo-Anota, Helen Y, et al.
Publicado: (2020)

El Immunepotent-CRP induce apoptosis en células leucémicas Molt-4.
por: Lorenzo Anota, Helen Yarimet, et al.
Publicado: (2019)

Nanoparticles for death‑induced gene therapy in cancer (Review)
por: Roacho Pérez, Jorge A., et al.
Publicado: (2017)

Peptide mimics of the thrombospondin C-terminal binding domain: Analysis of their therapeutic potential to trigger immunogenic death of cancer cells targeting the TSP1-CD47 axis
por: Gómez Morales, Luis
Publicado: (2021)

Peptide mimics of the thrombospondin C-terminal binding domain: Analysis of their therapeutic potential to trigger immunogenic death of cancer cells targeting the TSP1-CD47 axis
por: Gómez Morales, Luis
Publicado: (2021)

Chitosan gold nanoparticles induce cell death in HeLa and MCF-7 cells through reactive oxygen species production
por: Martínez Torres, Ana Carolina, et al.
Publicado: (2018)

IMMUNEPOTENT CRP plus doxorubicin/cyclophosphamide chemotherapy remodel the tumor microenvironment in an air pouch triple-negative breast cancer murine model
por: Santana Krimskaya, Silvia Elena, et al.
Publicado: (2020)

Copper Induces Damage, Oxidative Stress and Cell Death in Endothelium of Chronic Intoxicated Wistar Rats
por: Fernández Rodarte, Bernardo Alfonso, et al.
Publicado: (2022)

Study of the mechanism of cell death caused by peptides targeting CD47 in leukemia cell lines.
por: Gómez Morales, Luis
Publicado: (2017)

Study of the mechanism of cell death caused by peptides targeting CD47 in leukemia cell lines.
por: Gómez Morales, Luis
Publicado: (2017)

Ionizing radiation-induced DNA injury and damage detection in patients with breast cancer
por: Borrego Soto, Gissela, et al.
Publicado: (2015)

El IMMUNEPOTENT CRP disminuye la viabilidad en células A427 de cáncer pulmonar
por: Martínez-Loria et al., Alan
Publicado: (2017)

El IMMUNEPOTENT CRP disminuye la viabilidad en células A427 de cáncer pulmonar.
por: Martínez Loria, Alan Benancio, et al.
Publicado: (2015)

Recent applications of cell-penetrating peptide guidance of nanosystems in breast and prostate cancer (Review)
por: Longoria García, Samuel, et al.
Publicado: (2022)

Actividad citotóxica del IMMUNEPOTENT-CRP contra líneas celulares de cáncer pulmonar
por: Martínez-Loria, Alan
Publicado: (2018)

Actividad citotóxica del IMMUNEPOTENT-CRP contra líneas celulares de cáncer pulmonar.
por: Martínez Torres, Ana Carolina, et al.
Publicado: (2018)

El IMMUNEPOTENT-CRP induce la fosforilación de eIF2α, la liberación de DAMPs y la formación de autofagosomas en células HeLa y MCF-7
por: Reyes-Ruiz, Alejandra, et al.
Publicado: (2020)

El IMMUNEPOTENT-CRP induce la fosforilación de eIF2α, la liberación de DAMPs y la formación de autofagosomas en células HeLa y MCF-7.
por: Reyes Ruiz, Alejandra, et al.
Publicado: (2019)

Suppression of cell migration is promoted by miR-944 through targeting of SIAH1 and PTP4A1 in breast cancer cells
por: Flores Pérez, Ali, et al.
Publicado: (2016)

In vitro evaluation of the antitumor effect of bismuth lipophilic nanoparticles (BisBAL NPs) on breast cancer cells
por: Hernández Delgadillo, René, et al.
Publicado: (2018)

Efecto del immunepotent CRP en la respuesta clínica e inmunológica en pacientes con cáncer de mama
por: Garza Treviño, Elsa Nancy
Publicado: (2010)

Efecto del immunepotent CRP en la respuesta clínica e inmunológica en pacientes con cáncer de mama
por: Garza Treviño, Elsa Nancy
Publicado: (2010)

Efecto del IMMUNEPOTENT-CRP sobre células NK
por: Martínez Loria, Alan Benancio
Publicado: (2020)

Efecto del IMMUNEPOTENT-CRP sobre células NK
por: Martínez Loria, Alan Benancio
Publicado: (2020)

El IMMUNEPOTENT-CRP induce arresto en el ciclo celular y muerte celular regulada independiente de caspasas, pero dependiente de la producción de especies reactivas de oxígeno en células HeLa.
por: Benítez Londoño, Milena, et al.
Publicado: (2017)